chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On 10/15/2020 around 5:25 pm, patient showed up to pick up his medications. He further complained that since he received the vaccines on 9/18/2020, he had pain and discomfort on his left arm that received the immunizations. He complained that the pain was like radiating down to his palm and fingers. He stated that the heating pad helped somewhat.  Since it has been almost a month after the patient received the immunization, I recommended the patient to seek medical care from doctors.
screaming type cry 4 hrs p/shot; calm down w/APAP but repeated episode of crying later & called physician-saw MD;
12-04-07 PATIENT HAD TB TEST DONE AND FLU SHOT.  12-07-07 PATIENT HAD TB TEST READ, SHE SHOWED US HER LEFT FA WHERE SHE SAID SHE RECEIVED HER FLU SHOT, AREA ON LEFT FA RED, RAISED, APPROXIMATE SIZE OF PENNY.  NURSH ADM. FLUE SHOT INTRADERMALY.  ADMINISTRATOR AND DR NOTIFIED, NO TREATMENT NECESSARY.  ON-GOING FOLLOW UP WITH PATIENT REGARDING LOCAL REACTION. (PPD, SANOFI PASTEUR, C2805AA, INTERDERMALLY)
Infantile spasms started within 24 hours after vaccination. Treatment : sought medical care elsewhere without primary care physician unaware.
Patient returned to office on 9/2/09 at 2:52pm. Swelling around injection site and previous surgery scars. Pt. also complained of itching on hands and feet. .15cc of epinephrine was given. Eyelid swelling, rash on face, chest tight.
No adverse event. Vanish point needle failure, nurse administering vaccine pressed plunger to administer dose and vanish point retracted administering covid19 vaccine on patients arm, less than half the dose was given. Pharmacist was notified and dose was repeated in other arm without complications.
muscle soreness at the site of injection which lasted approximately 48 hours.; muscle soreness at the site of injection; This is a spontaneous report from a non-contactable pharmacist, the patient. A 38-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3180) via an unspecified route of administration in the left arm on 06Aug2021 at 15:00 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Concomitant medications included fluocinonide cream (MANUFACTURER UNKNOWN) for an unspecified indication from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Aug2021 at 20:00, the patient experienced muscle soreness at the site of injection which lasted approximately 48 hours. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event muscle soreness at the site of injection was recovered on 08Apr2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected
Lip swelling/hives/wheezing; Rx Epinephrine(1:1000) 0.2ml IM; Zyrtec 10mg po x1./ Recovered <30
pt recv vax 14OCT97 & on f/u day devel fever of 103 & was weak & very disoriented;lasted for 5 days then began to slowly recover;felt extremely ill;arm very sore for 5 days p/vax;
I had a scratchy throat, a headache for a day, and fatigue. I tested positive for COVID-19 at home. I went to the urgent care and they prescribed me PAXLOVID. I don't if it helped or not because I wasn't that sick. But I wasn't sick for a long time. I still have fatigue.
allergic rxn w/urticarial type rash following vax approx 15mins;VS T97.3, P140, R36 chest CTA; neg wheezing; skin urticarial type rash good profusion;tx epi, Solumedrol stat, d/c  on DPH
Constant cough, like a tickle, but felt like the beginning of pneumonia.  The cough was getting deep.  Sometimes coughed up a small wad of phlegm .Mone
Initial symptoms were difficult, but not totally unexpected: chills, fever, body aches, joint pain, headache, and fatigue that started about 10pm on the night of the vaccine (May 14th) and continued through early Sunday (May 16th) afternoon. On Tuesday (May 18th), my legs, buttocks, and arms broke out into a severe rash. Large welts, extremely itchy, and spreading quickly. I went to my doctor the same day to receive treatment after trying topical antihistamine cream and witch hazel, which provided little to no relief.
fever / high fever; This case was reported by a nurse via sales rep and described the occurrence of fever in a infant female patient who received HAV (Havrix) (batch number 9TL92, expiry date unknown) for prophylaxis.   On an unknown date, the patient received Havrix. On an unknown date, less than a year after receiving Havrix, the patient experienced fever (serious criteria hospitalization). On an unknown date, the outcome of the fever was unknown.   It was unknown if the reporter considered the fever to be related to Havrix.  Additional details were provided as follows: The age at vaccination was not reported. After vaccination, the patient had high fever. The patient's parent took the patient to hospital via ambulance and was admitted to the hospital.  The patient had additional vaccines at visit. The reporter consented to follow up.
Information has been received from a 31 year old female licensed practical nurse with no medical history or allergies who on an unspecified date when drawing up a dose of MMR II (rHA) (lot # 657638/1669U) a small amount splashed on the patient's face between the nose and eye. There was no concomitant medication. The patient did not feel that any of the vaccine got in the eye. It was reported that where the patient was splashed it felt different "perhaps numb". The patient reported rubbing the site and perhaps rubbed it too much. The patient sought unknown medical attention. The patient did not wish to be followed-up with. The outcome was reported as not recovered. A product quality complaint was not involved. No further information is available.
Myalgia, Arthralgia, Fever, chills and fatigue Narrative:
Swelling and redness to left shoulder. Feeling tired and nervous, arms felt heavy and warm.
Immunized at approx. 8am 7/30/04.  By 8pm c/o sore throat.  Lost voice by 12am & episodes of uncontrolled shaking w/out loss of consciousness x 15 min at approx. 2am.  Took two 200mg ibuprofen w/ relef in 5 min.  No fever or headache.  More tremors but improved w/ ibuprofen.  Did not seek medical care.
hard time breathing, tightness in chest using inhaler;bronchial tube congestion-dizzy, weak-difficulty concentrating;
I received the first shot with no problems on August 13, 2021. My second vaccine was on September 3, 2021 did not  have a reaction till the following day I had extreme head pain throbbing pressure and still continuous fast irregular heartbeats that wake me while sleeping almost everynight. I have a pulse oximeter and my heart rates is in 100 to 120 range while sleeping. Sometimes takes my breath away.
This is a 48-year-old female with PMH of Anemia presents to the ED for evaluation of shortness of breath. Patient reports her daughter was tested positive for COVID-19 on the 4th Nov. Since the 5th November patient started to experience headaches, congestion, low-grade fever of 100F, loss of smell, stomach discomfort. For a 24 hours patient is also experience shortness of breath. Patient was also tested positive for COVID-19. Patient was seen by the PMD today for assessment were she was noted to be mildly hypoxic so was referred to the ED.In the ED, patient had 2 sets of blood culture, DuoNeb, 6 mg of Decadron, Rocephin and Zithromax. Upon evaluation patient appears mild short of breath on exertion, and reports she feels weak.
pain with arm movement, cramp in left arm up to the fingers, left arm area hot to touch . doctor recommend painkiller
ekanthema, pharyngitis - Information has been received from a registered nurse concerning a 26 month old caucasian male patient with no known allergies and bilateral otitis media at the time of vaccination who on 25 Feb 1999 was vaccianted sc in the right arm with a first dose of varicella virus vaccine lot (lot 628242/1942H).  Comcomitant therapy included a first dose sc in the left arm of mealses mumps rubella vaccine (msd) lot 1850N- invalid and azithromycin (zithromax).  on 24  Apr 2000 the patient developed a varicella type rash and pharyngitis.  The patient was seen in the physician's office on 26 Apr 2000.  The patient recovered on an unspecified date.  No further information is expected.
Near immediate numbness going down left arm from site to hand with outer palm and all finger tips and thumb numb, intermittent burning pain in finger tips for over a week.
PATIENT REPORTS CHILLS, LOSS OF APPETITE, FEVER, NAUSEA, AND FATIGUE, WHICH LASTED FOR APPROXIMATELY TWO WEEKS.
SMALL ROUND RASH IN ABDOMEN/GROIN AREA. SHOWED UP AFTER RECEIVING VACCINE FOR FIRST DOSE AND PATIENT DIDN'T THINK ANYTHING OF IT, BUT THEN WHEN SHE RECEIVED SECOND VACCINE THE RASH SHOWED UP AGAIN AND SHE REALIZED IT WAS FROM VACCINE. SHE SAID THAT IT DOESN'T HURT OR ITCH AND IS ALREADY FADING, FASTER THAN IT DID THE FIRST TIME.
UPON ENTERING THE INFORMATION ON NYSIIS I HAD FOUND THAT EVEN THOUGH THE PATIENT STATED THAT HE HAD NEVER BEEN VACCINATED FOR COVID-19 . BY ANY OF THE THREE VACCINES THAT HE HAD INDEED BEEN VACINATED TWICE WITH THE MODERNA VACCINE  LOT#012C20A ON 1/12/21 AND ON 02/12/21 MODERNA LOT 012M20A AT URGENT CARE.
became fussy & devel low grade fever (38C), local erythema @ inj site w/induration & faint bruise an hr or so p/vax;w/APAP, motrin, cool compress;pt calmed down & went to sleep in clinic p/20min
Localized swelling at varicella vaccine inj site measured by physician today as 7 x 5cm. Tx with Hydroxyzine HCL tablet 25 mg 3 times daily.
Mom called patient started with arm soreness, nausea, dizziness when sanding and leg weakness today at school.
20 mcg dose administered to a 14-year-old; 20 mcg dose administered instead of a 10 mcg; This case was reported by a pharmacist via call center representative and described the occurrence of overdose in a 14-year-old female patient who received HBV (Engerix B adult) (batch number TB3KN, expiry date 3rd December 2023) for prophylaxis.   On 23rd November 2022, the patient received the 1st dose of Engerix B adult 20 µg. On 23rd November 2022, unknown after receiving Engerix B adult, the patient experienced overdose and adult product administered to child. On an unknown date, the outcome of the overdose and adult product administered to child were unknown.   Additional Information: GSK receipt date: 23-Nov-2022 Reporter's comment: The dose administrated was 20 mcg not 10 mcg dose. The vaccine administration facility was the same as primary reporter. The reporter agreed to follow-up. Additional supportive information: A dose of Engerix-B vaccine (20 mcg) had been administered to a patient of inappropriate age, which led to overdose and adult product administered to child.
Lump on left collar bone thats painful/lump by my collar bone thats sore and painful; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Lump on left collar bone thats painful/lump by my collar bone thats sore and painful) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Gastric bypass since 2009. Concurrent medical conditions included Anemic, Fibromyalgia and Bronchitis.    On 06-Jul-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jul-2021, the patient experienced LYMPHADENOPATHY (Lump on left collar bone thats painful/lump by my collar bone thats sore and painful). At the time of the report, LYMPHADENOPATHY (Lump on left collar bone thats painful/lump by my collar bone thats sore and painful) outcome was unknown.            No concomitant medication was provided.   No Treatment medication was provided.   Most recent FOLLOW-UP information incorporated above includes: On 09-Jul-2021: Follow-up information received contains non-significant information.
pt exp shoulder pain similar to a rotator cuff injury immed following inject of vax. pain is greater in the am. pt believes the inject was given improperly, was given 1 finger breadth below acromial process w/27 gauge needle
feel like I am in a fog; my chest was tight; my throat almost like a frog in my throat, like congested to try and cough and clear it up; cough; A little difficult breath, shortness of breath; I feel tired; on and off feeling bad/ I just don't feel like it or like doing anything; my back is tight; not feeling good enough to do anything/ I just don't feel good./haven't felt good at all; energy wise/I feel weak; This is a spontaneous report from non-contactable consumer (patient). A 60-year-old female patient received dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) via an unspecified route of administration on 19Mar2021 as a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. On an unspecified date the patient experienced on and off feeling bad, her back was tight, not feeling good enough to do anything or to exert herself energy-wise. Sometimes she went to the gym after work; she didn't feel like it or like doing anything. She didn't think she could get up and go to work. She just didn't feel good. She didn't know if it was the vaccine that was giving her a "rollercoaster ride." She did weights and cardio workouts. She worked out pretty hard but she had not done it like she used to. On 05Apr2021 she woke up in the morning and her chest was tight. Her throat almost like a frog in her throat like congested to try and cough and clear it up. A little difficult breath, shortness of breath but not real bad. Her breathing was okay now, tightness in her back and she felt tired. She was not the type of person that liked to sit around; it was like she was fighting it, and she didn't know what she was fighting. On 06Apr2021, she almost felt like she was in a fog; feeling like a fog started today (06Apr2021) and she stayed in bed until 10am. The patient stated "he" had a bad cold and was fine now. She was feeling kind of bad but not as bad as "he" was. She had only time, first time shortness of breath yesterday (05Apr2021). She had not felt good at all on and off since the vaccine. She was thinking pollen. She felt weak and did not feel good. The outcomes of on and off feeling bad, not feeling good enough to do anything, chest was tight, throat congested, cough, shortness of breath, tightness in her back, and feeling in a fog were unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
COVID 19 Treatment; COVID 19 Treatment; dose #1: Pfizer/ dose #2: Pfizer / dose #3: Pfizer / dose #4 Moderna / dose #5 Moderna; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 66-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 21Jan2021 as dose 1, single (Lot number: EL9261), in left arm, on 11Feb2021 as dose 2, single (Lot number: EN6201), in left arm and as dose 3 (booster), single (Lot number: FF2589) for 1 day, in left arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 31Mar2022 as dose 4 (booster), single (Lot number: 048L21A), in left arm and on 12Sep2022 as dose 5 (booster), single (Lot number: A57144B), in left arm for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 31Mar2022, outcome "unknown", described as "dose #1: Pfizer/ dose #2: Pfizer / dose #3: Pfizer / dose #4 Moderna / dose #5 Moderna"; VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: COVID 19 Treatment; Negative, notes: two days after negative; Negative, notes: two days after negative. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Additional information: no known allergies and other medical history. The patient was given PAXLOVID from 27Dec2022 to 31Dec2022 for treatment for COVID 19.
Few seconds after getting dose 2, client had vasovagal reaction. Patient was assisted, head protected and legs were elevated. Patient regained consciousness after 5 seconds. Ice pack was applied, water provided. Vitals signs taken X 4 and within normal limits. Patient left the site at 4:30 pm ambulatory and on stable condition.
She also developed a runny nose; developed a fever and chills; developed a fever and chills; This is a spontaneous report from a contactable consumer. This consumer reported for a 80-year-old female patient (reporter's mother-in-law). A 80-years-old female patient received first dose of bnt162b2 (BNT162B2, solution for injection), via an unspecified route of administration on 10Feb2021 (Batch/Lot number was not reported) as dose 1, single for covid-19 immunization.Medical history included constipation (had this many, many years), cerebrovascular accident and also had a stroke a month ago.There were no concomitant medications. On 14Feb2021, the patient experienced fever and chills and on 16feb2021, she also developed a runny nose.The patient underwent lab tests which included body temperature: 102 to 103 Fahrenheit on 14Feb2021and sars-cov-2 test was negative in 18Feb2021. It was reported that: the patient had the vaccine last Wednesday 10Feb at lunch time and reported that on Sunday night,14Feb was the first night patient had chills and fever at night, and the fever did not stop up until today, when it was getting worse. She has taken Tylenol to treat, which makes the fever go away.  First dose took a tylenol- fever went away, then the fever came back, and it was 102F. Highest reported fever was 102F. She also developed a runny nose on Tuesday, which seems to be resolving. She did not experience any injection site reaction or pain in her arm. The patient had a COVID-19 test using a test kit, and the result was negative. It is reported that patient fever got worse, and it was strange and the reporter doesn't know if this could be a reaction to the vaccine since it was Sunday night on the 14th four days after getting the vaccine on the 10th. Reporter said that he would like to know if this was a common reaction, but it happened so late, which was why they proceeded with the COVID test. It is reported that the patient also had a stroke a month and had been having PT until last week, they didn't stop her PT until she started having a fever. they didn't know if she got COVID before getting the vaccine, or while taking vaccine, her test was negative last night(18Feb2021).  It was reported that the patient started taking a blood thinner medication, with a common name, Aspirin. No further details provided about the Aspirin. He said she had a stroke a month ago, a mini stroke, and was released to a nursing facility until 2.5 weeks ago. she has recovered well, and can walk, she has been doing well through recovery and she was at the nursing home for a week, then stayed with him and his wife a week, then went back home. He clarified that his mother-in-law had the vaccine after she was out of the nursing facility for two weeks. He says she can walk without a walker and is recovering well. Therapeutic measures were taken as a result of fever. The patient recovered from fever on unspecified date in 2021 and outcome of the chill was unknown, and the patient was recovering from runny nose.  No follow-up attempts are possible, information about lot/batch number cannot be obtained.
Severe pain on right side of stomach. It was determined that I had a kidney stone (2/23/21) I was hospitalized for the stone on 2/25/21 due to kidney stone. . I'm otherwise a health individual with no prior issues with kidney stones. Ureteroscopy (2/26/21).
Pt recvd MMR in 1990 & w/in 2 hrs of vax devel wheezing & facial edema which were felt to be life-threatening; pt responded to tx w/adrenalin and/or DPH; addtl pts exp life-threatening allergic rxn;
About 10 hrs after the injection, not only was the muscle aching at the site of the injection but it travelled down the arm to the forearm. About 12 hrs after the injection, patient became nauseous with cold sweats. That lasted about 30 min. Primary care physician was contacted and was advised to go to urgent care if symptoms persisted. 24 hrs later, the arm pain was subsiding with the pain only at the injection site. After 48 hrs arm seems to be getting back to normal.
This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in an adult patient who received Herpes zoster (Shingle's vaccine).    On an unknown date, the patient received Shingle's vaccine. On an unknown date, unknown after receiving Shingle's vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingle's vaccine.  Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not reported. The patient had vaccination but still got the mild case. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, event onset time and laboratory confirmation for shingles were unknown at the time of reporting.
pt recv vax;swelling, no erythema, sl warmth, marked tenderness, lt axillary tender small adenopathy, approx 7x9cm x1cm swelling of lt deltoid;
itchy rash; SPOT LIKE RASH; This case was reported by a consumer via interactive digital media and described the occurrence of itchy rash in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   In July 2020, the patient received the 2nd dose of Shingrix. In July 2020, 2 weeks after receiving Shingrix, the patient experienced itchy rash and spot-like rash. On an unknown date, the outcome of the itchy rash and spot-like rash were unknown.   It was unknown if the reporter considered the itchy rash and spot-like rash to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The age group was selected as per vaccine indication. The patient received second shingrix vaccine about 2 weeks ago prior to reporting date.  At the time of reporting the patient had an unusual itchy rash.  The patient reported that it was in weird spots, like on throat, a couple on belly.  It was not a bug bite and had not changed anything.  The patient was curious.
Red bloodshot eyes that burned and kept getting goofy with whitish yellowish mucus. Coughing and clearing throat fit that lasted one hour. Pain and difficulty swallowing.